E6130 + Placebo
Phase 1Completed 3 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Japanese Healthy Adult Male Participants
Conditions
Japanese Healthy Adult Male Participants
Trial Timeline
Sep 26, 2016 → Aug 17, 2017
NCT ID
NCT02902978About E6130 + Placebo
E6130 + Placebo is a phase 1 stage product being developed by Eisai for Japanese Healthy Adult Male Participants. The current trial status is completed. This product is registered under clinical trial identifier NCT02902978. Target conditions include Japanese Healthy Adult Male Participants.
What happened to similar drugs?
3 of 20 similar drugs in Japanese Healthy Adult Male Participants were approved
Approved (3) Terminated (0) Active (17)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03390647 | Phase 1 | Withdrawn |
| NCT02902978 | Phase 1 | Completed |
Competing Products
20 competing products in Japanese Healthy Adult Male Participants